Proteins and nucleic acid molecules for inducing an immune response againsthuman telomerasereverse transcriptase ("hTERT") are provided. Pharmaceutical compositions,recombinantvaccines, and live attenuated pathogens for inducing an immune responseagainst hTERT arealso provided.